<DOC>
	<DOCNO>NCT02158234</DOCNO>
	<brief_summary>This study involve another course radiation ( call re-irradiation ) participant 's tumor . The type radiation call stereotactic body radiation therapy ( SBRT ) . The purpose study compare effect , good and/or bad , different dos SBRT give along chemotherapy drug , cisplatin . The researcher want see dose radiation work best control growth head/neck cancer . The usual treatment head/neck cancer grow surgery and/or radiation various chemotherapy drug .</brief_summary>
	<brief_title>Stereotactic Body Radiotherapy Concurrent Cisplatin Re-Irradiation Unresectable , Recurrent Squamous Cell Carcinomas Head Neck</brief_title>
	<detailed_description>Stereotactic Body Radiation Therapy ( SBRT ) relatively new radiation technique high dos radiation deliver small , well-defined tumor . It use effectively cancer like lung liver . The goal deliver radiation dose high enough kill cancer limit radiation surround healthy organ . The daily dose radiation 2-3 time great conventional radiotherapy , give 5 day 2 week period . Conventional radiotherapy give 6-7 week . The chemotherapy drug , cisplatin use radiation sensitizer give 5 radiation treatment .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Alkylating Agents</mesh_term>
	<criteria>Recurrence previously pathologically proven squamous cell carcinoma head neck , include original primary site paranasal sinus , nasal cavity , nasopharynx , oropharynx , oral cavity , larynx , hypopharynx , salivary gland , and/or involvement cervical lymph node Prior radiotherapy dose ≥ 45 Gy area recurrence , ≥ 6 month prior enrollment Eastern Cooperative Oncology Group ( ECOG ) Performance Status 0 2 Life expectancy &gt; 6 month Medically unfit surgery deem surgically unresectable head neck ( H &amp; N ) surgeon within 60 day prior enrollment , patient refusal surgery Normal organ marrow function No prior evidence Grade 3 great toxicity neuropathy Medically fit receive cisplatin Positive urine pregnancy test and/or breastfeeding . Women childbearing potential sexually active male must willing use effective contraception throughout participation treatment phase study . Evidence distant metastasis Tumor size &gt; 7 cm one direction Tumor within 1 cm spinal cord Cardiac history : class III great congestive heart failure ( CHF ) myocardial infarction ( MI ) within last 6 month Medical condition social situation discretion principal investigator ( PI ) would preclude completion trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>squamous cell carcinoma</keyword>
	<keyword>head neck cancer</keyword>
	<keyword>paranasal sinus</keyword>
	<keyword>nasal cavity</keyword>
	<keyword>nasopharynx</keyword>
	<keyword>oropharynx</keyword>
	<keyword>oral cavity</keyword>
	<keyword>larynx</keyword>
	<keyword>hypopharynx</keyword>
	<keyword>salivary gland</keyword>
	<keyword>cervical lymph node</keyword>
</DOC>